ReviewFrontiers in immunology2021

The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis.

Caterina Veroni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.